📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A long-acting GH receptor antagonist through fusion to GH binding protein. (2016)

First Author: Wilkinson IR

Attributed to: Development of a long-acting growth hormone antagonist to address the unmet need for treatment in acromegaly funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/srep35072

PubMed Identifier: 27731358

Publication URI: http://europepmc.org/abstract/MED/27731358

Type: Journal Article/Review

Volume: 6

Parent Publication: Scientific reports

ISSN: 2045-2322